AstraZeneca CEO says smaller first dose in COVID-19 vaccine is 'big plus'
LONDON, Nov 23 (Reuters) - AstraZeneca's chief executive officer Pascal Soriot said on Monday that the lower first dose of its experimental COVID-19 vaccine meant more people can be vaccinated more quickly, as the British drugmaker unveiled inter...
Read more